Zenas BioPharma, Inc. revenue breakdown overview

Zenas BioPharma, Inc. revenue for the last year amounted to 5.00 M USD, the most of which — 5.00 M USD — came from its highest performing source at the moment, Immune-based Therapies, the year earlier bringing 50.00 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Zenas BioPharma, Inc. 5.00 M USD, and the year before that — 50.00 M USD.